S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis

doi:10.4251/wjgo.v9.i8.314

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6243)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

296

WORD

227

HTML

2433

Figures (1-3)

181

Tables (1-2)

146

Sum=3283

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1228

Download

1732

Sum=2960

Aug 15, 2017 (publication date) through Jul 5, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Aug 15, 2017; 9(8): 314-318
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.314

Full Size Figure Download Figure

Figure 1 Abdominal computed tomography scans of a pancreatic cancer patient before (A) and during treatment (B) with S-1, showing that the liver/spleen ratio decreased after start of treatment.

Citation: Tsuji K, Doyama H. S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis. World J Gastrointest Oncol 2017; 9(8): 314-318
URL: https://www.wjgnet.com/1948-5204/full/v9/i8/314.htm
DOI: https://dx.doi.org/10.4251/wjgo.v9.i8.314